Skip to content

Biocon bets big on new class of weight-loss drugs

Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent

Read More

​ Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish